Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical trial and Pfizer Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 17:33 Post Lock Read More
Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical and head-to-head clinical study with Pfizer's Paxlovid_ Oriental Fortune Post date May 8, 2022 — 15:37 Post Lock Read More
Nuggets for innovative drugs Junshi Bio's new crown drug is in phase III clinical trial and Pfizer's Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 13:24 Post Lock Read More
Nuggets for innovative drugs Junshi Bio’s new crown drug is in phase III clinical trial and Pfizer Paxlovid conducts head-to-head clinical research Post date May 8, 2022 — 13:23 Post Lock Read More
Huang Liang a dream? Inke Medical has expanded production of 56 billion gloves in two years, and now its stock price and performance have both dropped by 90% – yqqlm Post date May 7, 2022 — 20:05 Post Lock Read More
Four-year huge loss of 6.4 billion, "China Disney" dream dragged down Huayi Brothers financial channel Rongyi Information Network Post date May 2, 2022 — 21:07 Post Lock Read More
Four-year huge loss of 6.4 billion, "China Disney" dream dragged down Huayi Brothers financial channel Rongyi Information Network Post date May 2, 2022 — 21:07 Post Lock Read More
Four-year huge loss of 6.4 billion, "China Disney" dream dragged down Huayi Brothers financial channel Rongyi Information Network Post date May 2, 2022 — 21:07 Post Lock Read More
Wen's shares fell 7.44%, CITIC Securities, Zhongtai Securities, Huachuang Securities, and high-singing wealth management channel Rongyi Information Network Post date May 2, 2022 — 18:43 Post Lock Read More
Affected by regional policy shutdowns and torrential floods, Zhengzhou Coal and Power will lose more than 200 million yuan in 2021 Post date April 19, 2022 — 13:33 Post Lock Read More
Caishen.CoCaishen.Co